Advertisement

Clinical Validation of a Continuous Monitoring Mobile Cardiac Detection Device for Atrial Fibrillation

Published:December 09, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.11.021
      Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with stroke being among the most prevalent and harmful outcomes.
      • Tanaka Y
      • Shah N
      • Passman R
      • Greenland P
      • Khan S.
      Trends in atrial fibrillation-related cardiovascular mortality rates in the United States: 1999–2017.
      Because nearly 25% of patients with AF appear asymptomatic, questions regarding the screening of patients at risk for AF (e.g., based on CHA2DS2-VASc score) could help clinical decisions to prescribe prophylactic anticoagulation therapy for effective stroke prevention.
      • Jaakkola J
      • Mustonen P
      • Kiviniemi T
      • Hartikainen JEK
      • Palomäki A
      • Hartikainen P
      • Nuotio I
      • Ylitalo A
      • Airaksinen KEJ.
      Stroke as the first manifestation of atrial fibrillation.
      ,
      • Esato M
      • Chun YH
      • An Y
      • Ogawa H
      • Wada H
      • Hasegawa K
      • Tsuji H
      • Abe M
      • Lip GYH
      • Akao M.
      Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry.
      Current evidence highlights new approaches of real-time continuous assessment of rhythmic states of AF, non-AF, and paroxysmal AF (PAF).
      • Chen LY
      • Chung MK
      • Allen LA
      • Ezekowitz M
      • Furie KL
      • McCabe P
      • Noseworthy PA
      • Perez MV
      • Turakhia MP
      • Cardiology American Heart Association Council on Clinical
      • Cardiovascular Council on
      • Nursing Stroke
      • Care Council on Quality of
      • Research; Outcomes
      • Council Stroke
      Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tanaka Y
        • Shah N
        • Passman R
        • Greenland P
        • Khan S.
        Trends in atrial fibrillation-related cardiovascular mortality rates in the United States: 1999–2017.
        Circulation. 2020; 141 (A15–A15)
        • Jaakkola J
        • Mustonen P
        • Kiviniemi T
        • Hartikainen JEK
        • Palomäki A
        • Hartikainen P
        • Nuotio I
        • Ylitalo A
        • Airaksinen KEJ.
        Stroke as the first manifestation of atrial fibrillation.
        PLoS One. 2016; 11e0168010
        • Esato M
        • Chun YH
        • An Y
        • Ogawa H
        • Wada H
        • Hasegawa K
        • Tsuji H
        • Abe M
        • Lip GYH
        • Akao M.
        Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry.
        Chest. 2017; 152: 1266-1275
        • Chen LY
        • Chung MK
        • Allen LA
        • Ezekowitz M
        • Furie KL
        • McCabe P
        • Noseworthy PA
        • Perez MV
        • Turakhia MP
        • Cardiology American Heart Association Council on Clinical
        • Cardiovascular Council on
        • Nursing Stroke
        • Care Council on Quality of
        • Research; Outcomes
        • Council Stroke
        Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association.
        Circulation. 2018; 137: e623-e644
        • Podd SJ
        • Sugihara C
        • Furniss SS
        • Sulke N.
        Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients.
        Europace. 2016; 18: 1000-1005
        • Castaneda D
        • Esparza A
        • Ghamari M
        • Soltanpur C
        • Nazeran H.
        A review on wearable photoplethysmography sensors and their potential future applications in health care.
        Int J Biosens Bioelectron. 2018; 4: 195-202
        • Paradkar N
        • Chowdhury SR.
        Cardiac arrhythmia detection using photoplethysmography.
        Annu Int Conf IEEE Eng Med Biol Soc. 2017; 2017: 113-116
        • Otsuka T
        • Kawada T
        • Katsumata M
        • Ibuki C.
        Utility of second derivative of the finger photoplethysmogram for the estimation of the risk of coronary heart disease in the general population.
        Circ J. 2006; 70: 304-310
        • Chen W
        • Khurshid S
        • Singer DE
        • Atlas SJ
        • Ashburner JM
        • Ellinor PT
        • McManus DD
        • Lubitz SA
        • Chhatwal J.
        Cost-effectiveness of screening for atrial fibrillation using wearable devices.
        JAMA Health Forum. 2022; 3e222419
        • Davidson KW
        • Barry MJ
        • Mangione CM
        • Cabana M
        • Caughey AB
        • Davis EM
        • Donahue KE
        • Doubeni CA
        • Epling Jr, JW
        • Kubik M
        • Li L
        • Ogedegbe G
        • Pbert L
        • Silverstein M
        • Stevermer J
        • Tseng CW
        • Wong JB
        • US Preventive Services Task Force
        Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement.
        JAMA. 2022; 327: 360-367